CorMedix (CRMD) Raw Materials (2019 - 2025)

CorMedix (CRMD) has 5 years of Raw Materials data on file, last reported at $3.6 million in Q4 2025.

• For the quarter ending Q4 2025, Raw Materials rose 227.18% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 227.18% YoY), and the FY2025 full-year result was $3.6 million, up 227.18% from the prior year.
• Raw Materials declined to $3.6 million in Q4 2025, from $7.0 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $7.0 million in Q3 2025 to a low of $603545.0 in Q3 2024.
• A 3-year average of $2.1 million and a median of $1.1 million in 2025 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials slipped 27.17% in 2024 and jumped 1062.75% in 2025, its largest moves.
• Tracing CRMD's Raw Materials over 3 years: stood at $1.5 million in 2023, then retreated by 27.17% to $1.1 million in 2024, then surged by 227.18% to $3.6 million in 2025.
• Business Quant data shows CRMD's Raw Materials at $3.6 million in Q4 2025, $7.0 million in Q3 2025, and $1.1 million in Q2 2025.